FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1103-1104 April 20, 1995 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Between June 1 and November 1, 1994, as part of an investigation of an outbreak of rubeola (measles), the Alaska State Health Department studied 57 persons with febrile illness accompanied by a rash. Efforts were made to obtain serum specimens from all persons with these symptoms during the investigation.

Using an enzyme immunoassay kit for rubeola IgM approved by the Food and Drug Administration, and commercially available, the State Public Health Laboratory identified 16 specimens that were positive for rubeola IgM, indicating acute rubeola illness. After noticing that several of the 16 people with IgM-positive specimens did . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Berth, M., Bosmans, E. (2009). Acute Parvovirus B19 Infection Frequently Causes False-Positive Results in Epstein-Barr Virus- and Herpes Simplex Virus-Specific Immunoglobulin M Determinations Done on the Liaison Platform. CVI 16: 372-375 [Abstract] [Full Text]  
• Tipples, G. A., Hamkar, R., Mohktari-Azad, T., Gray, M., Parkyn, G., Head, C., Ratnam, S. (2003). Assessment of Immunoglobulin M Enzyme Immunoassays for Diagnosis of Measles. J. Clin. Microbiol. 41: 4790-4792 [Abstract] [Full Text]